Strategic Wealth Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-35
Closed -$3.48K 576
2019
Q3
$3.48K Hold
35
0.02% 191
2019
Q2
$3K Sell
35
-65
-65% -$6.17K ﹤0.01% 686
2019
Q1
$9K Buy
100
+55
+122% +$4.81K ﹤0.01% 581
2018
Q4
$4K Buy
+45
New +$3.32K ﹤0.01% 606
2018
Q2
Sell
-173
Closed -$15K 866
2018
Q1
$15K Buy
173
+90
+108% +$8.64K 0.01% 437
2017
Q4
$9K Buy
+83
New +$9.37K 0.01% 556

Other funds holding CELG

Strategic Wealth Partners's CELG Position: Q4 2019 in Review

Strategic Wealth Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 35 shares — an estimated $3.48K sold.

Strategic Wealth Partners first reported a position in CELG in Q4 2017 and held it in 6 quarters. The position peaked at $15K in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Strategic Wealth Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Strategic Wealth Partners sold 35 Celgene Corp shares in Q4 2019, an estimated $3.48K.
  • Strategic Wealth Partners first reported a position in Celgene Corp in Q4 2017 and held it in 6 quarters.
  • Strategic Wealth Partners's Celgene Corp position peaked at $15K in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Strategic Wealth Partners's 13F filing for Q4 2019, filed 30 Jan 2020.